- Research works
- 26 ▼ 90% vs 2013–17
- Citations
- 1.1k 40.5 per fractional work
- Top-10% rate
- 18.9% record average 16.5%
- Open access
- 58% world 28%
Not ranked overall: Cerenis Therapeutics (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Cerenis Therapeutics (France)?
By fractional works in all years, weighted toward what it does more of than the world: Atherosclerosis, Cholesterol, Statins, Gene Therapy, Cardiovascular Disease, Obesity, C-Reactive Protein and Insulin Resistance.
- Epidemiology
- siRNA Delivery
- Lipid Metabolism
- Viral Vectors
- Chimeric Antigen Receptor
- AAV
- Immune Response
- RNA-Guided
- Cancer
- Inflammation
- Diabetes
- Cardiovascular Disease Prevention
- Insulin Resistance
- Obesity
- Gene Therapy
- Cholesterol
- Atherosclerosis
- Statins
- Cardiovascular Disease
- C-Reactive Protein
- Metabolic Syndrome
- Cholesterol-lowering
- Glucose Metabolism
- Lifestyle Intervention
- Genome Engineering
- Cancer Immunotherapy
- Genomic Integration
- CAR T Cells
- Metabolism
- Fatty Acid Synthase
- RNA Interference
- Dendritic Cells
- Macrophage
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 33 words, with their numbers
- Atherosclerosis4▲ 46×6 topics
- Cholesterol4▲ 93×3 topics
- Statins4▲ 169×2 topics
- Gene Therapy3▲ 41×3 topics
- Cardiovascular Disease2▲ 8.8×4 topics
- Obesity2▲ 13×4 topics
- C-Reactive Protein2▲ 109×2 topics
- Insulin Resistance2▲ 20×3 topics
- Metabolic Syndrome2▲ 11×4 topics
- Cardiovascular Disease Prevention2▲ 112×1 topic
- Cholesterol-lowering2▲ 176×1 topic
- Diabetes2▲ 17×2 topics
- Glucose Metabolism2▲ 82×1 topic
- Inflammation2▲ 3.4×12 topics
- Lifestyle Intervention2▲ 102×1 topic
- Cancer2▲ 5.6×8 topics
- Genome Engineering2▲ 134×1 topic
- RNA-Guided2▲ 134×1 topic
- Cancer Immunotherapy2▲ 46×2 topics
- Immune Response2▲ 11×3 topics
- Genomic Integration2▲ 59×2 topics
- AAV1▲ 74×1 topic
- CAR T Cells1▲ 118×1 topic
- Chimeric Antigen Receptor1▲ 118×1 topic
- Metabolism1▲ 7.5×3 topics
- Viral Vectors1▲ 74×1 topic
- Fatty Acid Synthase1▲ 122×1 topic
- Lipid Metabolism1▲ 122×1 topic
- RNA Interference1▲ 43×1 topic
- siRNA Delivery1▲ 64×1 topic
- Dendritic Cells1▲ 37×2 topics
- Epidemiology1◆ 1.01×5 topics
- Macrophage1▲ 74×2 topics
Which research topics does Cerenis Therapeutics (France) publish most on?
By volume in 2022–2025: Ultrasound and Hyperthermia Applications, Photoacoustic and Ultrasonic Imaging, Hepatocellular Carcinoma Treatment and Prognosis and Advanced Radiotherapy Techniques.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ultrasound and Hyperthermia Applications Biomedical Engineering 0 works
- 2 Photoacoustic and Ultrasonic Imaging Biomedical Engineering 0 works
- 3 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
- 4 Advanced Radiotherapy Techniques Radiation 0 works
- 5 Advanced Sensor Technologies Research Biomedical Engineering 0 works
- 6 Advanced MRI Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 7 Heat Transfer and Boiling Studies Mechanical Engineering 0 works
- 8 Advanced Thermodynamic Systems and Engines Mechanical Engineering 0 works
- 9 Infrared Thermography in Medicine Radiology, Nuclear Medicine and Imaging 0 works
- 10 Thermal Regulation in Medicine Critical Care and Intensive Care Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cerenis Therapeutics (France)'s research output changed?
Output in 2018–2022 was 90% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Labège
- Noveltis (France)
- Physiogenex (France)
- GTP Technology
- IntuiLab (France)
- Dendris (France)
- Genticel (France)
- ORME (France)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.